Skip to main content

Table 1 Clinicopathological data in the distal cholangiocarcinoma cohort (N = 59)

From: Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker

Variable

N

n (%), mean ± SD

Age

59

67 ± 8.1

Sex

59

 

 Female

 

20 (34%)

Adjuvant therapy

  

 Yes

58

30 (52%)

Tumor size (mm)

59

29 ± 9.6

Tumor differentiation

59

 

 High

 

0

 Intermediate

 

16 (27%)

 Low

 

43 (73%)

T stage

59

 

 I

 

2 (3.4%)

 II

 

0

 III

 

56 (95%)

 IV

 

1 (1.7%)

Lymph node metastases

58

 

 Present

 

40 (69%)

AJCC stage

58

 

 IA

 

1 (1.7%)

 IB

 

0

 IIA

 

17 (29%)

 IIB

 

39 (67%)

 III

 

1 (1.7%)

R1 resection

59

 

 Present

 

34 (58%)

Lymph vessel invasion

57

 

 Present

 

42 (74%)

Nerve invasion

58

 

 Present

 

48 (83%)

Blood vessel invasion

58

 

 Present

 

37 (64%)

Adipose invasion

59

 

 Present

 

48 (81%)

  1. AJCC American Joint Committee on cancer, R1 non-radical resection, SD standard deviation, T stage Tumor stage
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us